Introduction: Studies focusing on enchondroma and atypical cartilaginous tumour (ACT) of the pelvis are lacking. The purpose of this study was to verify possible clinical and radiological findings with regard to distinguishing enchondromas from ACT of the pelvis. In addition, this study analysed functional and oncological outcomes in patients with enchondromas or ACT of the pelvis treated with curettage or resection. Materials and methods: We retrospectively reviewed the medical records of 21 patients with confirmed enchondroma or ACT of the pelvis treated by curettage or resection from 1985 to 2018. The minimum follow-up was 18 months. The relationship between clinical and radiological factors and tumour type or local recurrence was a...
none5noAbstract BACKGROUND: Studies for patients with pelvic chondrosarcomas are limited. This stud...
Introduction: Extraskeletal myxoid chondrosarcoma (EMC) is a rare tumor of cartilaginous origin, mos...
Introduction: Enchondromas are among the most current benign bone tumours. Malignant degeneration is...
Introduction: Studies focusing on enchondroma and atypical cartilaginous tumour (ACT) of the pelvis ...
Introduction: The purpose of our study is to verify possible clinical and radiological findings with...
Abstract Background Sufficient data on outcome of patients with clinically and radiologically aggres...
Item does not contain fulltextBACKGROUND AND OBJECTIVES: Intralesional surgical treatment is the pre...
The differentiation between the atypical cartilaginous tumor (ACT) and the enchondromas is crucial a...
As of today two types of cartilage tumors remain a challenge even for the orthopedic oncologist: enc...
Management of atypical cartilaginous tumors (ACTs) in the long bones is shifting towards active surv...
Copyright © 2012 Eugenio M. Ferrer-Santacreu et al. This is an open access article distributed under...
Atypical cartilaginous tumours (ACT) are tumours arising in bone and mainly only locally aggressive....
Background: A central atypical cartilaginous tumor (ACT)-formerly known as chondrosarcoma grade 1 (C...
Background: Enchondroma is the most common benign tumor of the bones of the foot. Chondrosarcoma in ...
Background: A central atypical cartilaginous tumor (ACT)-formerly known as chondrosarcoma grade 1 (C...
none5noAbstract BACKGROUND: Studies for patients with pelvic chondrosarcomas are limited. This stud...
Introduction: Extraskeletal myxoid chondrosarcoma (EMC) is a rare tumor of cartilaginous origin, mos...
Introduction: Enchondromas are among the most current benign bone tumours. Malignant degeneration is...
Introduction: Studies focusing on enchondroma and atypical cartilaginous tumour (ACT) of the pelvis ...
Introduction: The purpose of our study is to verify possible clinical and radiological findings with...
Abstract Background Sufficient data on outcome of patients with clinically and radiologically aggres...
Item does not contain fulltextBACKGROUND AND OBJECTIVES: Intralesional surgical treatment is the pre...
The differentiation between the atypical cartilaginous tumor (ACT) and the enchondromas is crucial a...
As of today two types of cartilage tumors remain a challenge even for the orthopedic oncologist: enc...
Management of atypical cartilaginous tumors (ACTs) in the long bones is shifting towards active surv...
Copyright © 2012 Eugenio M. Ferrer-Santacreu et al. This is an open access article distributed under...
Atypical cartilaginous tumours (ACT) are tumours arising in bone and mainly only locally aggressive....
Background: A central atypical cartilaginous tumor (ACT)-formerly known as chondrosarcoma grade 1 (C...
Background: Enchondroma is the most common benign tumor of the bones of the foot. Chondrosarcoma in ...
Background: A central atypical cartilaginous tumor (ACT)-formerly known as chondrosarcoma grade 1 (C...
none5noAbstract BACKGROUND: Studies for patients with pelvic chondrosarcomas are limited. This stud...
Introduction: Extraskeletal myxoid chondrosarcoma (EMC) is a rare tumor of cartilaginous origin, mos...
Introduction: Enchondromas are among the most current benign bone tumours. Malignant degeneration is...